Randomized, controlled, multicenter phase III trial of standard-dose fluorouracil-epirubicin-cyclophosphamide (FEC), compared with time-intensive FEC (FEC-G) and mitoxantrone-methotrexate-mitomycin C (MMM-G) in metastatic breast carcinoma. (Q33348421)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Randomized, controlled, multicenter phase III trial of standard-dose fluorouracil-epirubicin-cyclophosphamide (FEC), compared with time-intensive FEC (FEC-G) and mitoxantrone-methotrexate-mitomycin C (MMM-G) in metastatic breast carcinoma.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Randomized, controlled, multicenter phase III trial of standard-dose fluorouracil-epirubicin-cyclophosphamide (FEC), compared with time-intensive FEC (FEC-G) and mitoxantrone-methotrexate-mitomycin C (MMM-G) in metastatic breast carcinoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

phase III clinical trial

0 references

multicenter clinical trial

0 references

Paolo Pedrazzoli

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Capotorto AM

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Pavesi L

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Da Prada GA

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Zamagni C

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Massidda B

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Farris A

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Martoni A

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Lelli G

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Robustelli della Cuna G

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 April 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Journal of Chemotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

184-191

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

Exact significance testing to establish treatment equivalence with ordered categorical data

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella I

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.184

21 January 2018

Identifiers

10.1179/JOC.2003.15.2.184

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12797397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33348421&oldid=1536720266"